SUPPORTING THE RACE FOR A COVID-19 THERAPY
A top-tier pharmaceutical company posed the ultimate challenge to Almac Clinical Technologies: Can you provide IRT support for a COVID-19 study with only one week lead time? Using Almac Clinical Technologies’ novel IRT product, Simplify™, the work started the very next day. In this unique situation, the timeline clearly would not allow for a “business as usual” option. This case study exemplifies how Almac Clincial Technologies was able to expedite the implementation of IRT in support of pandemic research efforts.
YOU WILL LEARN:
- How an unprecedented level of Sponsor-Supplier collaboration & communication solved major challenges under such short and uncertain circumstances
- About the speed and possibilities of Almac Clinical Technologies’ novel IRT product, Simplify™
- How Simplify was designed from the ground-up to support clinical trials where time and agility are of the essence
Free Instant Access
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to [email protected]. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.